Dexcom, Inc., headquartered in San Diego, California, is dedicated to helping people better manage their diabetes by providing exceptional continuous glucose monitoring (CGM) products and tools for adult and pediatric patients. Our latest-generation CGM, the Dexcom G5™ Mobile CGM System, is the first FDA-approved, fully mobile System for both adults and children 2 years and older. Patients can not only view their real-time glucose data via their smart device*, but also share it with loved ones without needing a receiver. Our CGM features customizable alerts and alarms to warn patients of highs and lows and how quickly they may be happening. We also offer Dexcom CLARITY™, an advanced reporting tool for users to identify their unique glucose patterns, while also discovering potential solutions to help them spend more time in their target range. For more information, visit www.dexcom.com.
*For a list of compatible devices, please visit www.dexcom.com/compatibility
After years of research, including thousands of in-depth conversations with people with diabetes and health care providers, Tandem Diabetes Care® brings you the t:slim® Insulin Pump, the first insulin pump with a touch screen that embodies a fresh new design approach and offers the most requested features in a next-generation insulin pump. It’s no surprise that the t:slim Pump is ranked #1 in overall user satisfaction and product features. We are equally proud of the fact that, despite our rapid growth, Tandem’s Customer Support is also ranked #1 among pump companies. (Reference: dQ&A Patient Panel, 2H 2014)
Abbott Diabetes Care, a division of global health care company Abbott, is committed to improving the lives of people with diabetes. The company manufactures, distributes and markets innovative glucose monitoring systems and offers valuable services to help patients and healthcare professionals better manage diabetes care needs. Abbott Diabetes Care is pleased to be a sponsor of the 2016 Friends for Life® conferences. For more information, visit www.abbottdiabetescare.com.
With a shared vision of creating a world without limits for people with diabetes, the Johnson & Johnson Diabetes Care Companies are a collaboration of Johnson & Johnson companies dedicated to diabetes and includes LifeScan, Inc., a world leader in blood glucose monitoring; Animas Corporation, maker of innovative insulin delivery systems; Calibra Medical, Inc. developer of OneTouch Via™ on-demand insulin delivery; and the Johnson & Johnson Diabetes Institute, LLC, a global initiative to improve care and better outcomes worldwide through education and training programs. At Animas, we’re committed to addressing key unmet needs of patients with diabetes across the continuum of care, and are steadfast in our pursuit of meaningful innovation. The Animas® Vibe® Insulin Pump & CGM System is our most advanced insulin pump to date, and is the only integrated pump and continuous glucose monitoring (CGM) system approved for children as young as 2 years of age. Animas is pleased to be a Supporting Sponsor of Friends for Life® Anaheim 2016. To learn more about Animas, the Animas® Vibe® System or the OneTouch Ping® Glucose Management System, please visit www.Animas.com.
A world leader in diabetes drug delivery for nearly 90 years, BD is dedicated to improving the patient experience at every touch point, ensuring highest quality devices and clinical education services to enable better diabetes therapy and outcomes. BD Pen Needles and Insulin Syringes are designed with leading technology to enable more effective injection through improved comfort, convenience, safety and environmental sustainability. BD devices support earlier initiation and better adherence to prescribed therapies to help diabetes patients around the world live healthier lives.
In 1923, the founders of Novo Nordisk began a journey to change diabetes. Today, we are thousands of employees across the world with the passion, the skills and the commitment to continue this journey to prevent, treat and ultimately cure diabetes. Novo Nordisk is proud to once again be a Platinum Level Sponsor of the Friends for Life® conference, supporting the Family and Friends Banquet and Sports Central. Please come see us at the exhibition to learn more about our type 1 support program, our new camp program and be among the first to learn about the first and only durable insulin pen with 0.5 unit doing and memory function - NovoPen Echo®. To learn more about Novo Nordisk and our support to the Type 1 diabetes community visit us at www.novonordisk-us.com.
Friends of CWD
Beta Bionics, Inc., is a Massachusetts public benefit corporation committed to innovating, developing, commercializing, and disseminating the iLet®, a dual-hormone bionic pancreas for people living with T1D. Our stated benefit mission is (1) to provide a turnkey solution for safe and effective autonomous glycemic control, (2) to bring this technology to as many people with T1D as possible, (3) to continue to innovate and to offer the latest advances, and (4) to act in the best possible interest of the T1D community. As a benefit corporation founded by parents of children with T1D, Beta Bionics, unlike any other medical technology company, is protected under Massachusetts law to prioritize its benefit mission and place the best interests of the T1D community ahead of all other considerations. Beta Bionics is pleased to be a Supporting Sponsor of Friends for Life® Anaheim 2016. To learn more about Beta Bionics, the iLet, and our public benefit mission, visit us at www.betabionics.org and @BetaBionics on social media.
Since 1985, the Pediatric-Adolescent Diabetes Research and Education (PADRE) Foundation has been dedicated to improving the lives of the youth and families living with Type 1 diabetes by providing exceptional education, support and events for all children with diabetes, as well as for their parents and siblings. We believe we can inspire kids to lead AMAZING lives until a cure for Type 1 diabetes is found. For more information, visit the PADRE Foundation website at www.padrefoundation.org or call 714-509-8330.
Insulet Corporation is an innovative medical device company dedicated to improving the lives of people with diabetes. Insulet's OmniPod® Insulin Management System is a revolutionary insulin infusion system – the first and only tubeless system in the US – that gives kids the freedom to be kids, and parents the peace of mind of continuous insulin therapy. The OmniPod® system packs all the functionality of today's "smart" insulin pumps in two discreet, easy-to-use wireless parts, featuring an integrated FreeStyle® blood glucose meter, and, best of all, no cumbersome tubing. The remote Personal Diabetes Manager (PDM) allows parents and caregivers additional control, and with OmniPod’s® convenient auto-cannula insertion, your child never has to see or handle a needle. To learn more and hear from real OmniPod® users, please visit www.MyOmniPod.com. Insulet is delighted to support Friends for Life® Anaheim.
JDRF is the leading global organization focused on type 1 diabetes (T1D) research. Driven by passionate, grassroots volunteers connected to children, adolescents, and adults with this disease, JDRF is now the largest charitable supporter of T1D research. The goal of JDRF research is to improve the lives of all people affected by T1D by accelerating progress on the most promising opportunities for curing, better treating, and preventing T1D. JDRF collaborates with a wide spectrum of partners who share this goal. In addition to our research funding and leadership, JDRF’s outreach efforts provide practical support and resources for people with T1D and their families every step of the way as they live with T1D. JDRF is proud to partner with Children with Diabetes by sponsoring regional and national conferences as a charity partner, and supporting sessions at Friends for Life®. For more information, visit the JDRF website at www.jdrf.org, or call 800-533-CURE.
The American Diabetes Association is the nation's leading nonprofit health organization providing diabetes research, information and advocacy. Founded in 1940, the American Diabetes Association conducts programs in all 50 states and the District of Columbia, reaching hundreds of communities. The Association is also the largest single provider of camps for children with diabetes with 53 sessions of day and residential camps throughout the nation. Each year, the Association serves hundreds of families as they confront school discrimination issues through our Safe at School initiative. The Association is leading the movement to Stop Ignorance, Stop Discrimination, Stop Complications and ultimately to Stop Diabetes. At www.diabetes.org, you will find great information and opportunities to interact with other kids and parents affected by type 1 diabetes. Connect with your local American Diabetes Association office at 1-888-DIABETES or visit our website at www.diabetes.org.
[ Report | Presentations | Photos | Sponsors ]
|Return to the Top of This Page|
Last Updated: (none)
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.
This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents. Our mission is to provide education and support to families living with type 1 diabetes.
© Children with Diabetes, Inc. 1995-2018. Comments and Feedback.